Preventing Overdose Deaths with Naloxone: Harm Reduction vs Encouraging Use - Frankly Speaking EP 296
b'Credits: 0.25 AMA PRA Category 1 Credit\\u2122\\n\\xa0\\nCME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-296\\n\\xa0\\nOverview: The number of drug overdoses in the United States continues to rise in tandem with the growing opioid epidemic. In 2020, nearly 92,000 people died from drug overdoses in the United States, which was an approximate 31% increase in just one year. This episode will highlight perceived barriers to harm reduction and show primary care providers how they can play a key role in overdose prevention.\\xa0\\n\\xa0\\nEpisode resource links:\\n\\nhttps://www.cdc.gov/opioids/overdoseprevention/reverse-od.html\\n\\n\\nhttps://www.cdc.gov/drugoverdose/deaths/index.html#:~:text=Drug%20Overdose%20Deaths%20Remain%20High&text=Opioids%E2%80%94mainly%20synthetic%20opioids%20(other,of%20all%20drug%20overdose%20deaths).\\n\\n\\nBonner, L. (2022). As the opioid epidemic takes a turn for the worse, do we need more potent forms of naloxone?. Pharmacy Today, 28(3), 26.\\n\\n\\nMessmer, S., & Jarrett, J. (2022). When Naloxone Isn\\u2019t Enough. New England Journal of Medicine.\\n\\n\\nTse, W. C., Djordjevic, F., Borja, V., Picco, L., Lam, T., Olsen, A., ... & Nielsen, S. (2022). Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a \\u2018moral hazard\\u2019associated with naloxone supply. International Journal of Drug Policy, 100, 103513.\\n\\n\\xa0\\nGuest: Mariyan L. Montaque, DNP, FNP-BC\\n\\xa0\\nMusic Credit: Richard Onorato'